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Downstream processing is currently the major bottleneck for bioproduct generation. 
In contrast to the advances in fermentation processes, the tools used for downstream 
processes have struggled to keep pace in the last 20 years. Purification bottlenecks 
are quite serious, as these processes can account for up to 80% of the total production 
cost. Coupled with the emergence of new classes of bioproducts, for example, virus-like 
particles or plasmidic DNA, this has created a great need for superior alternatives. 
In this review, improved downstream technologies, including aqueous two-phase 
systems, expanded bed adsorption chromatography, convective flow systems, and 
fibre-based adsorbent systems, have been discussed. These adaptive methods are 
more suited to the burgeoning downstream processing needs of the future, enabling 
the cost-efficient production of new classes biomaterials with a high degree of purity, 
and thereby hold the promise to become indispensable tools in the pharmaceutical 
and food industries.
The downstream processing (DSP) of 
biopharmaceuticals is generally more cost-
intensive than corresponding upstream (fer-
mentation) processes in the biotech industry 
and can account for up to 80% of production 
costs. Moreover, with significant advances 
in fermentation technologies, which have 
resulted in titers of over 20 g/l [1], related 
developments in downstream bioprocessing 
have failed to keep up in terms of scale and 
product recovery. An additional challenge 
that modern downstream practices need 
to address is the targeting of new classes of 
bioparticles, such as monoclonal antibodies 
(mAbs), pDNA, virus-like particles (VLPs) 
or nanoplexes, as well as whole cells 
(e.g., stem cells). These different bioproducts 
and expression systems require a toolbox 
of robust and scalable techniques to satisfy 
desired purity and yield in a sustainable and 
cost-effective manner.
Linear scale-up of traditional DSP meth-
ods of harvest clarification, concentration, 
and primary recovery have reached their 
limits and are unable to meet current prod-
uct demand, not only in terms of space 
requirements, but also in terms of cost, 
resource consumption and process time. 
Consequently, technologies that offer pro-
cess integration, that is, a reduction in the 
number of unit operations in the initial iso-
lation and purification steps while maintain-
ing high product recovery and purity, would 
not only increase process economy but also 
reduce process time. However, chromato-
graphic separations, which require extensive 
feedstock pre-treatment, have been among 
the most essential operations in the down-
stream processing of biopharmaceutical 
products. Additionally, several chromato-
graphic steps are needed to fulfil the high 
demands regarding product purity, consis-
tency, and safety [2,3]. Chromatography is a 
relatively slow process and requires expen-
sive separation media and large volumes of 
aqueous mobile phases. Therefore, faster 
production cycles, reduced consumable 
needs, and/or a reduction of chromato-
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graphic steps within established 
downstream processes would result 
in a significant decrease of overall 
production cost [4,5]. The concept of 
process intensification refers to any 
process adaptation or optimization 
that results in a less resource-inten-
sive biomanufacturing scheme, 
including, but not limited to, lower 
water consumption, energy demand 
and environmental burden. 
This review will primarily focus 
on multifaceted approaches address-
ing process integration and intensi-
fication based on the utilization of 
non-traditional chromatographic or 
extractive methods, which include 
advances in bioprocess material 
development, hardware design and 
advantageous modes of operation.
While adsorptive methods, such 
as chromatography, are widely used 
in industry as a key purification 
technology, liquid–liquid extraction 
technologies, such as aqueous two-
phase separation (ATPS) systems, are 
elegant emerging examples of pro-
cess integration. In this technique, 
direct extraction of bioproducts 
from crude feedstocks can be accom-
plished by the use of two incompat-
ible polymers or of a polymer and a 
salt in an aqueous environment. It is 
a powerful technique that combines 
moderate to high selectivity, high recovery and high 
biocompatibility.
A complementary solid–liquid extraction technique, 
which also allows for the direct sequestration of a tar-
geted bioproduct directly from a crude feed, thereby 
integrating conventional clarification, concentration, 
and initial purification into a single unit operation, 
is expanded bed adsorption (EBA) chromatography 
(Figure  1) [6,7]. Converse to traditional packed-bed 
chromatography, EBA employs a fluidized adsorbent 
bed, where fluidization is driven by the flow rate of the 
mobile phase, which is entering the system from the 
bottom of the column. Larger biological particles, such 
as whole cells or cell debris, are allowed to flow unhin-
dered through the interstitial voids within the fluid-
ized column, while the product of interest is allowed 
to selectively bind to the adsorbent. Additionally, 
as a result of the relatively high flow rates employed 
compared with packed-beds, process times can also be 
drastically reduced.
The successful scale-up of convective flow systems, 
an example of which are the so-called monoliths [8], 
have also allowed unprecedented reductions in pro-
cess times as well as increased recovery rates for the 
purification of extremely large biomolecules, such 
as pDNA and VLPs [9–11]. These unique chromato-
graphic media have overcome the limitations of con-
ventional porous bead adsorbents, which were initially 
designed for much smaller molecules. Convective 
forces, such as flow rate, the ability to control mass 
transport in these systems, and larger external pore 
sizes can consequently accommodate increasingly 
larger biomolecules [12].
Finally, innovative fibrous adsorbent media that 
offer faster process times and are easily integrated 
within current infrastructures can also lead to high-
performance disposable systems that meet strict 
health, safety, and quality requirements. For example, 
cellulose and other natural polymers have been tra-
ditionally used in the recovery and purification of 
proteins; they have been industrially processed into 
specific shapes, such as spherical adsorptive micro-
particles [13] and thin ultra/microfiltration membranes, 
among others [14]. A novel composite fibre technology 
known as gPore has been introduced, and offers new 
kinds of adsorptive supports based on natural fibrous 
materials, which are packed in various open-structure 
arrangements. More recently, they have been delivered 
as non-woven structures as well, which have exhibited 
reproducible packing properties as well as compatibility 
with non-clarified feedstock.
Another important trend that has generated an 
increasing amount of interest lately is the transition 
from traditional batch-based downstream process-
ing regimens to continuous processes [15,16]. In this 
respect, methods to transform the technologies dis-
cussed in this review into continuous processes exist 
in the form of simulated moving bed-type systems 
and their variants [17–20]. Alternatively, promising 
methods, such as continuous countercurrent tan-
gential chromatography have shown exceptional 
results [21,22]. Despite the considerable inertia of the 
biopharmaceutical industry to move away from their 
established methods, the move towards continuous 
processing could potentially revolutionize the way 
bioproducts, especially pharmaceuticals, are pro-
duced, in a way similar to how continuous operation 
modes have done in case of other industries, that is, 
petrochemical, paper, food or glass. The ability of 
continuously operated processes to produce higher 
purity goods at competitive prices will make it 
imperative to consider the possible application of any 
new downstream processing methods to be utilized 
in such a fashion [23].
Key Terms
Monoclonal antibodies: Class of 
biological therapeutics based 
on antibodies of the exact same 
structure and properties that have 
risen to prominence in the last 
decade for targeted treatment of 
various diseases. 
pDNA: Circular DNA used for 
gene therapy and vaccine 
formulations; A novel class 
of emerging therapeutic 
bioproducts. 
Virus-like particle: Novel class 
of very large molecule used for 
vaccination purposes, bearing 
structural similarity to actual 
viruses, without the infectious 
payload, which are difficult to 
process due to their large size. 
Aqueous two-phase separation: 
Process of selective product 
isolation from complex mixtures 
by employing two immiscible 
aqueous phases.
Expanded bed adsorption 
chromatography: 
Chromatographic method 
employing a fluidized bed 
for product capture and 
concentration from complex 
feedstock in a single step.
Monolith: Macroporous single-
block chromatographic material 
enabling mass transfer solely 
by convection, which facilitate 
high flow rates leading to faster 
process times.
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ATPS
ATPS has been recently revisited for the purification 
of biomolecules, including biopharmaceuticals such 
as mAb, growth hormones and growth factors with 
very impressive results, which in some cases surpassed 
established chromatographic processes [24]. 
One of the key advantages of ATPS over tradi-
tional techniques is the possibility of handling solid-
containing feedstock, and consequently, its application 
in the early stages of the purification, thereby integrat-
ing the clarification and capture of the target biological 
product in a single unit operation (Figure 1). Another 
important feature of ATPS is its feasibility of opera-
tion in continuous mode, which is particularly relevant 
when continuous bioreactors are used in the upstream 
process. This permits immediate clarification and 
subsequent processing of labile biomolecules.
Aqueous two-phase systems are formed spontane-
ously upon mixing two solutions of different poly-
mers (e.g., PEG, dextran, ethylene oxide propylene 
oxide co-polymer [EOPO], polyacrylates), or a 
polymer and a kosmotropic salt (e.g., phosphate, 
sulphate, citrate), above a certain concentration. 
This phenomenon was first observed in 1896, but its 
potential as a technique for the separation of biologi-
cal products was only recognized around 1956, with 
the work of Albertsson [25]. Since then, extraction 
in aqueous two-phase systems has been successfully 
used for the fractionation and purification of biologi-
cal samples containing cells, cell organelles, nucleic 
acids, proteins, and peptides, among others [26–28]. 
In fact, ATPS constitutes a gentle technique for the 
separation of biomolecules, since not only the bulk 
of both phases contain 70–90% of water, but also 
because most polymers and salts can have a stabilizing 
effect on protein structure. Table 1 summarizes some 
of the biological products that have been purified by 
aqueous two-phase extraction [29–46,201].
Partitioning of biomolecules in ATPS depends 
on several parameters, both intrinsic and extrinsic. 
Intrinsic parameters are governed by the properties of 
the target biomolecule, including size, electrochemical 
properties, surface hydrophobicity and conformational 
characteristics. Extrinsic parameters reflect the char-
acteristics of the two-phase system, including type, 
molecular weight and concentration of phase form-
ing components; ionic strength, pH, temperature and 
presence of additives such as affinity ligands, among 
others [26]. If these extrinsic parameters are properly 
chosen, highly selective windows can be opened for the 
purification of the target biomolecules. 
The application of ATPS at the process scale has, 
however, been described only for few biomolecules, 
including insulin-like growth factor I [34] and human 
growth factor [47]. This fact can be attributed to the 
following causes: 
 » The mechanisms that govern the partition of 
biomolecules are not fully understood, although 
some trends can be established with hydrophobic-
ity being one of the key determinants of protein 
partitioning [27]; 
 » Method development and optimization is rather 
empirical and laborious, requiring testing many 
different parameters at the same time; 
 » Difficulties may occur during scaling up or scaling 
down the process;
 » Validation of impurity clearance, including the 
phase-forming components (e.g., polymers) may 
not be straight forward and may make product 
approval more difficult by regulatory agencies. 
In the particular case of mAbs, a questionable 
platformability of extraction compared with the 
Protein A capture platform can also be pointed out.
One strategy to make partitioning in ATPS more 
predictable and selective is to add affinity ligands to 
one of the phases and thus direct the partition of the 
target biomolecule towards the phase containing fewer 
impurities. Different authors have employed this strat-
egy, where both PEG and dextran have been modified 
with different types of ligands (Table  1). Additional 
Traditional DSP
Harvest Harvest
ATPS EBAClarication
Capture and concentration
Intermediate purication
Viral clearance
Polishing
Intermediate purication
Viral clearance
Polishing
Integrated DSP
Figure 1. Process flow sheet comparison between a traditional 
downstream process and an integrated approach, where clarification, 
concentration and capture can be integrated in a single step. 
ATPS: Aqueous two-phase separation; DSP: Downstream processing; 
EBA: Expanded bed adsorption.
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sophistications of these methods by utilization of affin-
ity micro- or nano-particles are known, as well [48]. The 
use of soluble ligands, however, adds an extra impurity 
to be removed in downstream unit operations.
Another interesting approach to ease process devel-
opment is by using design of experiments to speed up 
process optimization and, at the same time, facilitating 
a more thorough evaluation of the process variables. 
Many published studies make use of a central compos-
ite design to optimize the ATPS composition, in terms 
of polymer type and molecular weight, ionic strength, 
pH and tie-line length. Another possibility to improve 
process development is to use high throughput screen-
ing techniques such as robotic pipetting stations 
[49,50] or microfluidic devices [51]. Both tools have the 
potential to effectively accelerate bioprocess design and 
optimization in a cost effective manner.
Two significant aspects that could further foster the 
use of ATPS at large scale are that:
 » Scale-up has been described as easy and reliable [52];
 » The systems can be processed in continuous mode 
using typical liquid–liquid extractors such as 
mixer-settlers or extraction columns [53–55]. 
Recently, a continuous ATPS process incorporating 
three different steps (extraction, back-extraction, and 
washing) was set up and validated in a pump mixer-
settler battery (Figure  2). This ATPS process allowed 
the recovery of IgG from a CHO cell supernatant 
with a global recovery yield of 80%, a final total 
purity of 97% and protein purity of more than 99%. 
A PER.C6 cell supernatant was also processed with a 
total recovered yield of 100%, a final total purity of 
97% and an HCP purity of 95% [54]. The economic 
viability of this ATPS process has been evaluated and 
compared with the currently established platform 
based on Protein A chromatography [24]. The ATPS 
process was shown to be considerably advantageous 
in terms of process economy and operation, espe-
cially when high titre cell culture supernatants were 
processed (> 2.5 g/l). It is able to continuously purify 
the same level  of mAbs, reducing the annual variable 
operating costs by at least 39%. 
One of the key features of ATPS is to be amenable 
to process integration and intensification. ATPS can be 
used to purify biomolecules directly from a crude feed-
stock, that is, from unclarified cell cultures/broths, 
with or without additives such as antifoam. In this case 
the cell harvest is directly integrated with the capture 
step without any clarification step in between (Figure 1). 
Indeed, different ATPS systems have been effectively 
used as primary recovery steps in the purification 
of biomolecules, produced in either prokaryotic or 
eukaryotic hosts. Proteins produced in Escherichia coli 
generally form inclusion bodies or are secreted into the 
periplasmic space and need to be clarified to remove 
cell debris and solubilized to yield the active protein. 
Table 1. Purification of biological products from distinct sources using aqueous two-phase systems.
Biologicals Source System Ref.
Non-functionalized ATPS
IgG Hybridoma CCS PEG/phosphate/NaCl [29]
IgG CHO CCS PEG/phosphate/NaCl [30,31]
IgG CHO CCS PEG/citrate [32]
IgG Hybridoma CCS PEG/citrate/NaCl [33]
Insulin-like growth factor Escherichia coli cell debris PEG/sulphate [34]
HBsAg Saccharomyces cerevisiae PEG/sulphate [201]
Human alpha-1 antitrypsin Natural milk whey PEG/citrate [35]
Rotavirus-like particles Insect cell culture homogenate PEG/phosphate [36]
B19 virus-like particles Sf9 Insect cell culture paste PEG/ammonium sulphate [37]
pDNA E. coli lysates PEG/sodium citrate/ ammonium sulphate [38]
pDNA E. coli lysates PEG/ammonium sulphate [39]
Functionalized ATPS
IgG CHO CCS PEG-glutaric acid/dextran [40]
IgG CHO CCS PEG/dextran/TEG-COOH [41]
IgG Hybridoma cell culture PEG-mimetic green/ dextran [42,43]
pDNA E. coli lysates PEG/dextran/PEG-IDA-Cu(II)/DNA binding fusion protein  
(LacI-His6-GFP)
[44]
pDNA E. coli lysates PEG/dextran/PEGylated PEI [39]
Red blood cells Sheep and human RBC mixture PEG-antibody/dextran [45]
Hematopoietic stem cells Umbilical cord blood PEG/dextran/anti-CD34 antibody [46]
ATPS: Aqueous two-phase separation; CCS: Cell culture supernatant; CHO: Chinese hamster ovary; HBsAg: Hepatitis B surface antigen.
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Typically, these processes suffer from low efficiency 
due to the high viscosity and density of the bulk solu-
tions, caused by the presence of high concentrations 
of chaotropic agents (e.g., 4 M urea), which can make 
subsequent solid–liquid separations (e.g., centrifuga-
tion) difficult. ATPS can be successfully used in these 
cases either after (when inclusion bodies are formed) 
or simultaneously with cell disruption (when soluble 
proteins are formed), allowing not only the removal of 
cell debris and host cell proteins and DNA, but also 
the preservation of protein activity. These integrated 
processes have been described and successfully applied 
in the purification of insulin-like growth factor [34] and 
human growth hormone [47]. It must be noted that sys-
tem composition can be affected by the presence of a 
fermentation broth. Hence, researchers should expect a 
change in composition when passing from preliminary 
studies performed with pure proteins in diluted buf-
fers to studies with real feedstocks. Interestingly, phase 
separation typically occurs for lower concentration of 
polymers when real feedstocks are used. Nevertheless, 
these strategies will definitely contribute to a dramatic 
cut on the manufacturing costs of bioproducts and to 
an increase in product integrity and stability, which, 
when combined, will ultimately lead to the production 
of more affordable products. 
Further advances in ATPS can arrive from the use of 
non-conventional phase-forming components, such as 
ionic-liquids, surfactants and stimuli-responsive poly-
mers, including temperature-, pH- and photo-respon-
sive polymers. These ‘smart polymers’ (see Table  2) 
offer a rather convenient way to recycle the polymer 
by simply changing environmental conditions such as 
temperature, pH, ionic strength or light [56–66]. Most 
partitioning studies have been performed using the 
thermo-responsive EOPO copolymer, which can be 
easily recycled through thermoseparation. Increasing 
the temperature above the polymer’s cloud point 
induces the formation of a two-phase system, where 
the concentration of EOPO polymer in the bottom 
phase is usually 40–60%, while the top phase con-
tains almost 100% water [57]. Typical phase-forming 
components such as PEG or dextran are more difficult 
to recycle and commonly require specifically designed 
unit operations. These could include:
 » Diafiltration or dialysis with an ultrafiltration 
membrane;
 » Organic solvent extraction followed by evaporation 
of the solvent; 
 » Crystallization for salt components; 
 » Specific adsorption techniques such as lectin or 
boronate chromatography for dextran or other 
carbohydrate-based polymers. Nevertheless, the 
cost involved in developing and validating these 
unit operations may not justify this option.
BP outlet
Washing
Extraction Back-extraction Washing
BP outlet
Extraction
TP inlet
Extraction
BP inlet
Extraction
CS TP outlet
Back-extraction
BP inlet
Back-extraction
TP outlet
Washing
TP inlet
Washing
Figure 2. Continuous aqueous two-phase separation-based process flow diagram, designed for the purification 
of human antibodies from a cell culture supernatant. This includes an extraction step performed in six stages 
where most high-molecular-weight impurities are removed, followed by a single-stage back-extraction step and ending 
with a washing step performed in three stages, which allows removal of low-molecular-weight compounds. Numbered 
rectangles represent the different stages of the extraction step; circles with crosses represent mixing pumps. 
BP: Bottom phosphate-rich phase; CS: Cell supernatant; TP: Top PEG-rich phase.
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Second generation expanded bed 
adsorption chromatography
EBA chromatography is based upon the utilization of 
a bed of fluidized and classified adsorbent beads; the 
expansion of which is controlled by the upward flow 
rate of the mobile phase at the bottom of the column. 
The method relies on a population of adsorbent beads 
with defined particle size and density distribution that 
causes a restricted local mobility of the individual 
adsorbent particles along the height of the column. 
The downward gravitational force experienced by the 
particles is balanced by upward viscous forces exerted 
by the mobile phase following Stoke’s law. Crude feed-
stock containing the product of interest can be directly 
loaded into a fluidized column containing beads 
of appropriate functionality, and can be effectively 
washed to eliminate trace non-binding contaminants 
(Figure  3). Elution can then be carried out either in 
expanded mode or packed-bed mode.
This new concept for the isolation of bioproducts 
employing fluidized adsorbent 
beads was introduced by Draeger 
and Chase more than two decades 
ago [67]. This early work was exclu-
sively performed with common 
Sepharose beads [67,68]. Soon after, 
particles weighted by a quartz-
core were introduced [69]. The 
pharmaceutical industry previ-
ously employed fluidized beds for 
the recovery of antibiotics. This 
included batch systems for strep-
tomycin and semi-continuous 
methods for novobiocin [70,71]. 
Since its introduction, EBA chro-
matography has been employed for 
protein purification in a wide array 
of expression systems, for example, 
mammalian, bacterial, yeast, as 
well as algal systems along with 
their homogenates [72–74]. EBA also 
allows for immediate processing of 
ElutionSedimented
bed
Equilibration
and classified
fluidization
Sample
application
and wash
Figure 3. Principle of expanded bed adsorption chromatography.
Table 2. Smart polymers used for aqueous two-phase extraction.
Copolymer (trade name) Composition Mr
 (Da) Characteristics Ref.
EO50PO50
(UCON 50-HB-5100;
UCON 50-HB-3520;
UCON 50-HB-2000)
Co-polymer of EO and PO composed of 50% EO 
and 50% PO
5100;
3520;
2000
Temperature responsive (CPT 
1% solution = 50–53°C)
[56]
EO50PO50
(Breox PAG 50A 1000)
Co-polymer of 50% EO and 50% PO 3900 Temperature responsive (CPT 
10% solution = 50°C)
[57]
EO30PO70 Co-polymer of 30% EO and 70% PO 5000 Temperature responsive (CPT 
10% solution = 40°C)
[57]
HM-EOPO C14H29-group coupled to the end of the polymer 
EOPO composed of 66 EO and 14 PO groups
8000 Temperature responsive (CPT 
3% solution = 14°C)
[58]
Poloxamers 
(Pluronic)
Triblock co-polymercs of EO-PO-EO
(%EO 10–80%)
1100–8400 Temperature responsive
(CPT = 5–65°C)
[59]
pAEDS Polymer composed by 
diallyaminoethanoatedimethyl sulfoxide
35,000 pH responsive (precipitates with 
the addition of 0.95 eq. HCl)
[60]
pDAB Copolymer of 2-(dimethylamino) ethyl methacrylate, 
acrylic acid, and butyl methacrylate (5.8:17.7:1)
37,000 pH responsive (precipitates at 
pH = pI = 4.1)
[61]
pNNC Copolymer of N-isopropylacrylamide (NIPA), 
N-vinyl-2-pyrrolidone (NVP), chlorophyllin sodium 
copper salt (177:9:2)
7100 Light responsive (precipitates 
by irradiation with visible light at 
488 nm)
[62]
CPT: Cloud point temperature; EO: Ethylene oxide; PO: Propylene oxide.
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sensitive products, for example, proteins that are sub-
ject to protease attack. Process times are decreased by 
more than 50% [75]; corresponding product recovery 
and purity are comparable to conventional multi-step 
methods [76].
After EBA had been commercially introduced in 
the early 1990s, shortcomings of the technology soon 
became apparent in day-to-day operations. The first 
generation of EBA adsorbents, which consisted of 
slightly heavier agarose-based beads, (e.g., possessing 
a core of quartz, zirconia, metals or alloys) promoted 
unfavorable biomass–adsorbent interactions (Figure 4), 
which in turn provoked the failure of many proposed 
industrial processes [77–79]. These interactions intro-
duced a variety of detrimental effects, such as particle 
agglomeration, improper bed fluidization leading to 
channelling and stagnant zones, reduced product 
binding capacity, and elutriation of the adsorbent (due 
to reduction in its specific weight), among others. In 
some cases, for certain combination of feedstock type 
and adsorbent mode, a complete collapse of the fluid-
ized bed was observed. The adverse effects of different 
biomass types on adsorbents of different composition 
are found extensively in literature 
[80]. Furthermore, the low density 
of these adsorbent beads limited the 
maximum flow rate that could be 
employed, leading to longer process 
times. However, the development of 
second-generation EBA adsorbents 
(e.g., DSM Rhobust™) has led to 
significant improvements in EBA 
performance [81]. These high-den-
sity tungsten carbide-cored beads 
coated with cross-linked agarose are 
available in several types of func-
tionality (IEX, HIC, mixed-mode, 
or affinity) and possess sufficient 
densities (~2.8–3.2 g/ml) to offer 
much higher operational flow rates, 
in the range of 300–600 cm/h [76]. 
The higher drag forces associated 
with faster flow velocities also con-
tribute to biomass detachment from 
the bead leading to lower buffer 
consumption [82]. Coupled with an 
effective and uniform flow distribu-
tion system, such as the rotating 
fluid distributor, this technology is 
now scalable up to 60 cm (internal 
diameter) columns (Rhobust™ 
Flex system) [76]. Additionally, ideal 
bed expansion factors for optimal 
product capture have been deter-
mined to be within 1.8–2.2-times the sedimented bed 
height [83], and while changes in mobile phase viscos-
ity (e.g., between buffer and crude feedstock) might 
lead to bed instability, sensitive ultrasonic detectors 
have been adapted to the expanded bed systems, which 
automatically adjust flow rates to maintain ideal bed 
expansion via a feedback loop [84]. Numerous examples 
clearly highlight the huge potential contained in the 
EBA methodology [85–87]. Excluding the cost of adsor-
bents, an economic advantage of up to 50–70% has 
been reported by Walter and Feuser [88]. These results 
are directly linked to the reduction of necessary unit 
operations from three to four in a traditional purifi-
cation scheme to just one for EBA [88]. To generate a 
well-fluidized and efficient processing system based 
on EBA, a key element is controlling the deposition of 
biomass, which will be discussed below.
On one hand, experimental techniques have been 
developed, which allow for performance evaluation 
via key indicators, such as finite bath cell adsorption, 
the cell transmission index via pulse experiments, and 
residence time distribution analysis, which indicates 
proper fluidization and operation of the expanded 
Cell interaction
Cell aggregation
Figure 4. Binding of Saccharomyces cerevisiae yeast cells onto Streamline DEAE (average 
size 200 µm). (A) The interaction and aggregation of yeast cells onto the Streamline DEAE. (B) No 
cell interaction onto Streamline SP (a negative control for no cell interaction). (C) Low interaction of 
yeast cell onto PVP-coated Streamline DEAE. 
Reproduced with permission from reference [93] © Elsevier (2012).
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bed under real process conditions [85]. On the other 
hand, further process optimizations of EBA towards 
reducing biomass–adsorbent interactions have recently 
emerged in the form of theoretical investigations into 
the physico-chemical properties of the beads, biomass, 
as well as the mobile phase [89,90]. These involve the use 
of refined colloid theory methods (extended DLVO 
theory) that take into account hydrophobic, polar, and 
electrostatic interactions between colloidal entities [91]. 
When Coulomb-type interactions are predominant, 
it has been shown that assessing the surface charges 
of cells and adsorbents (via zeta potential measure-
ments) suffices as a quick screening method to evaluate 
biomass–adsorbent interactions [85].
Several strategies, guided by theoretical calculations 
described earlier, can be applied in order to optimize 
process conditions and minimize biomass–adsorbent 
interactions [85]. For example, increasing the ionic 
strength of the mobile phase eliminates most electro-
static interactions. Additionally, adjusting the pH of 
the system results in altered zeta potentials [92]. These 
adjustments in conditions can be coupled to appropri-
ate adsorbent design, for example, by shielding the 
bead surface with cell repellent polymers (Figure  4) 
[93], yielding an integrated strategy for EBA process 
development [85]. Together with the significant recent 
technological innovations mentioned earlier, second 
generation EBA has finally matured into a competitive 
downstream technology that will prove disruptive to 
current practices in the biotechnology industry. 
Convective flow systems
In conventional chromatographic separations, the 
product of interest is carried along with all the sol-
uble impurities through the solid stationary phase, 
for example a chromatographic resin packed in the 
column, with the flow of a liquid mobile phase. The 
components present in the mixture are separated 
according to the differences in migration rates that 
arise from the differences in the physical proper-
ties (size-exclusion chromatography), interaction 
strengths (ion-exchange and hydrophobic interaction 
chromatography) or affinity properties (affinity chro-
matography). The movement of the solutes between 
the two phases and through the column, however, can 
be driven by either diffusion or convection. Diffusion 
mass transport is a random thermal movement that is 
driven by concentration differences of the component 
in space, and is inversely proportional to the size of 
the component. Therefore, diffusion is a process that 
always takes time and can be accelerated only to a 
certain extent. On the other hand, convective mass 
transport is induced by an external force, such as a 
pressure difference, where the mass transfer rate is 
controlled by an external flow rate, usually induced 
by gravity or a pump, and is practically independent 
of molecular size.
Conventional chromatographic matrices for bio-
chromatography were first developed for the purifi-
cation of small protein molecules and were beaded 
particles ranging in size from 50 to 500 µm, having 
pores with diameters of up to 30 nm [12,94] to gain 
enough surface area to reach high binding capacities 
for small proteins. Mass transfer through the column 
packed with beads is based on convection (the mass 
transfer between the particles) and diffusion (the mass 
transfer into the pores of the particle). For a very small 
species (e.g., ions or small organic molecules) the dif-
fusion coefficients are high and the time needed for 
the molecule to enter the pore is relatively short. The 
increase in the flow rate does not significantly influence 
the efficiency of the column. On the other hand, large 
molecules (e.g., proteins, pDNA and VLPs) for which 
the diffusion coefficients are at least two orders of 
magnitude lower and the transfer of the molecule into 
the pore is additionally hindered due to the small pore 
diameter/molecule diameter ratios (d
P
/d
M
 ≤ 10 [12]), 
more time is needed for the molecule to diffuse into 
the pore. Consequently, column characteristics, such 
as resolution and dynamic binding capacity, decrease 
considerably when the flow rate increases. Regarding 
the purification of very large compounds, the acces-
sibility of the active surface in conventional beads is 
an issue; since the size of large antibodies (IgM) is in 
the range of 20 nm and the size of pDNA, VLPs and 
viruses is much larger (above 100 nm), these com-
pounds cannot enter small pores. Subsequently, the 
available surface for binding decreases dramatically, 
since most of the macromolecules bind to the outer 
shell of the beads, and as a consequence, the capacity 
drops from more than 130 mg/ml for small proteins to 
1.5 mg/ml or lower for, for example, pDNA [95].
To avoid diffusion and capacity limitations, new 
chromatographic media were developed, such as 
non-porous and perfusion particles, chromatographic 
monoliths, and membranes (Figure 5). Non-porous par-
ticles completely eliminated diffusion limitations, lead-
ing to significantly enhanced mass transfer. However, 
as a result of low active surface area, being only on the 
outer surface of the particle, capacities are also low. 
This can be overcome by using smaller particles, but 
columns packed with these particles exhibit extremely 
high back pressures [4].
Perfusion particles have additional flow through 
pores of larger diameter (0.6–0.8 µm) within the 
particle, where the molecules are additionally trans-
ported by convection. They still contain smaller 
closed pores to gain the sufficient surface area to bind 
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small proteins as conventional porous matrices, but 
those pores are still too small for pDNA or viruses to 
enter, which permits the binding of these molecules, 
once again, solely at the surface of macropores [95]. 
Moreover, since flowthrough pores in the particle are 
much smaller than pores in the inter-particle space, 
most of the mobile phase flows around the particles 
rather than through the perfusion pores due to the 
lower back pressure, thereby diminishing the con-
vective effect [96]. Membranes are another type of 
convective-based support that have excellent hydro-
dynamic properties. However, because of the low 
surface area and high dead volume that enhance extra 
column effects they lack the capacity and resolution 
(selectivity) [10].
To overcome most of the problems listed above for 
different types of chromatographic supports, chro-
matographic monoliths were introduced. They con-
sist of a single block of material that contains highly 
connected flow through macropores that enable the 
transport of the solute to the surface solely by convec-
tion. Silica monoliths, prepared by sol–gel synthesis, 
also contain mesopores and are developed for the 
separation of small molecules. While the polymeth-
acrylate monoliths, having only macropores, are the 
most widely used monoliths for protein, pDNA, and 
virus separation, purification and concentration, their 
physical structure ensures that their entire surface 
area is accessible for large molecules to bind, which 
results in very high capacities for large solutes. For 
example, the capacity of polymethacrylate monoliths 
ranges from 8 up to 14 mg/ml for pDNA [97–99] and 
from 109 pfu/ml to more than 1012 pfu/ml for viruses 
[100–102], depending on the virus and impurity con-
centration present. As a consequence of the convec-
tive mass transport, they exhibit flow-independent 
resolution and binding capacity for all sizes of bio-
pharmaceuticals. Before the year 2000, chromato-
graphic monoliths were tested for only laboratory and 
small preparative purposes. In that year, however, 
Podgornik and co-workers published the principle 
of constructing large monolithic columns that were 
based on a radial geometry column design [103]. Based 
on this, the scale-up of monolithic columns was suc-
cessfully solved [8] and the polymethacrylate mono-
lithic columns, also known as Convective Interaction 
Media (CIM) monoliths, have become very interest-
ing for industrial applications. It is notable, however, 
that the size of these media is currently limited to 
a maximum of 8 L columns, which will need to be 
amplified in the future for larger scale applications. 
Although the obvious trade-off for CIM media is 
the relatively lower quantitative binding capacities as 
compared with higher surface area beaded adsorbents 
(see Table 3), CIM trumps these beaded adsorbents by 
offering a far superior method to purify new classes of 
enormous bioparticulate entities such as pDNA and 
viral particles.
One of the first industrial applications of CIM 
chromatographic monoliths was purification of 
pDNA by Boehringer Ingelheim [104]. Before the 
most appropriate chromatographic support was cho-
sen, a thorough comparison study was performed 
[99,105], which showed the best binding capacity for 
plasmids and practically flow-independent properties 
for monolithic columns (Figure  6). The productivity 
of the process was also calculated and it was shown 
that by using monolithic columns a 15-times higher 
productivity could be achieved. At that time no HIC 
monolith was commercially available, therefore, the 
first purification step (using HIC) was still performed 
on the conventional bead matrices. However, because 
of various advantages using CIM monolithic columns 
in the downstream processing of pDNA, progress has 
been made and new purification processes have been 
developed using solely monolithic chromatographic 
columns which have, consequently, achieved much 
higher process productivity [11].
The increased vaccine production and the need for 
large quantities of purified viral vectors for a promis-
ing new field of gene therapy emerging at the end of 
the previous century led to an intensive search for new 
tools to substitute the conventional purification tech-
niques such as density gradient ultracentrifugation, 
precipitation and two-phase extraction. Namely, these 
methods were unable to deliver fast, efficient, and scal-
able downstream processes for these biopharmaceuti-
cals. Chromatography was soon recognised as the most 
promising tool for these purposes but the size of viral 
particles presented a huge challenge for conventional 
particle packed columns, while polymethacrylate 
monoliths with previously described characteristics 
were ideally suited for the task. Since then, numerous 
Diffusive
particles
Perfusive
particles
Monoliths Stacked
membranes
Convection
Diffusion 
Figure 5. Mass transport in contemporary chromatography formats [10]. 
Areas of diffusive transport are indicated in yellow, convective transport in 
white, and support matrix in blue.
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plant, human and bacterial viruses (tomato mosaic 
virus, bacteriophage T4, influenza, adenovirus and 
lentivirus, to name just a few) were successfully puri-
fied using CIM monolithic columns [106–109]. Increased 
productivity of monoliths compared with conventional 
virus purification methods was demonstrated with dif-
ferent viruses and bacteriophages [9,107]. A very illustra-
tive demonstration as to how the introduction of CIM 
monolithic chromatography into the DSP of viruses 
can shorten the process was shown with tomato mosaic 
virus, where DSP was shortened from 5 days to only 
2 h (Figure 7).
Fibre-based adsorbent systems
Cellulose is one of the most abundant polymers in 
nature. It is found in the cell walls of green plants as 
a structural component. Made up of 200 to tens of 
thousands of b-linked d-glucose units, its stability is 
mainly due to the hydrogen bonds formed between 
the hydroxyl groups of the juxtaposed chains. This 
arrangement leads to compact, water-insoluble mico-
fibrils, despite the hydrophilic nature of its building 
blocks.
The cellulosic microfibrils are arranged into crystal-
line domains, with a high degree of organization, and 
amorphous domains. In the case of cotton cellulose 
fibres, a 65–70% degree of crystallinity is observed, 
which stems from the hydrogen bridges formed 
between the polymer chains. However, some hydroxyl 
groups remain available for hydrogen bonding interac-
tions with water in this phase. In contrast, all hydroxyl 
groups, even the ones in the interior, are accessible in 
the amorphous phase and are available for further direct 
chemical modification [110], which is advantageous for 
increasing binding capacities of fibre-based adsorbents. 
However, the utilization of functionalized cellulose 
fibres creates a pellicular type of adsorbent, which in 
turn increases the resolving power of the system. 
For chemical or biochemical applications, cellulose 
is most commonly employed in the granular or beaded 
form as a stationary phase in partition chromatogra-
phy, for example in thin layer chromatography or as 
beads packed in a column, thereafter used for the 
separation of a multitude of molecules, ranging from 
organic compounds to macromolecules and biopoly-
mers. Cellulose and its major derivatives, nitro- and 
acetate cellulose, are also employed in DSP, mainly in 
the filtration, clarification and ultrafiltration processes 
of cell suspensions and protein-rich solutions. It is also 
used as an adjuvant, to facilitate the removal of cells 
and cellular debris, colloids and insoluble material. 
More recently, electrospun cellulose nanofibers, with 
high internal surface area, have been studied as a novel 
protein adsorbent material [111]. This material shows T
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similar binding capacity and per-
meability as compared with com-
mercial adsorptive membranes, and 
offers similar process advantages as 
the gPore materials discussed herein. 
Cotton fibres contain more than 
95% cellulose, with varying length 
and fibre diameters between species 
[112]. Egyptian cotton (Gossypium 
barbadense) is particularly appro-
priate for the development of 
adsorptive fibrous material, due 
to its extra-long and thin fibres 
(extra-long-staple). Native cotton 
fibre has a highly ordered and low 
water-absorbing structure. Alkali-
treatment, such as mercerization, 
is traditionally used to partially 
loosen this ordered structure, lead-
ing to a swelling of the cotton lint-
ers. Additionally, alkali treatments 
reduce crystallinity and increase the 
accessibility of cellulose hydroxyl 
groups to the solvent [113]. However, 
further chemical modifications 
are necessary for a permanent 
stabilization of the swollen polymer.
Recently, fibrous materials have 
become an interesting subject for further research, 
due to their facile functionalization and beneficial 
physiochemical properties. They are rapidly becoming 
a viable alternative to beaded adsorbents (in packed 
bed mode), due to their competitive cost and excel-
lent process factors, such as yield and purity. The most 
prominent feature is the ability to apply a wide variety 
of different functionalities to the fibre-matrix, making 
these materials adaptable and versatile. The function-
alization of the fibres can be facilitated with various 
chemical and physical methods.
Ionizing radiation was applied to induce graft 
polymerization of the swelled cellulose with poly-
methacrylates to add selective adsorptive properties 
[114,202]. The gPore composite material contains more 
than 60% cellulose, preserving the 3D fibre structure. 
Water uptake experiments, as well as microscopy 
images, revealed that the grafting modification does 
not disturb the physical integrity of the material. This 
is due to the highly penetrative nature of gamma rays, 
permitting a homogenous and efficient modification of 
the material [202].
Confocal microscopy demonstrates the protein 
adsorption capability in the bulk fraction of gPore 
fibres with IgG labelled with Cy3 fluorescent dye 
electrostatically adsorbed to the fibre wall, which 
is composed of a sulfopropyl poly-methacrylate/
cellulose composite. The protein diffusion path in 
the fibre wall is shorter than 10 µm, compared with 
a more than five-times longer path in the beaded 
materials [115].
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Figure 7. Comparison of conventional tomato mosaic virus purification 
and tomato mosaic virus purification using CIM QA monolithic support. 
Reproduced with permission from [107] © Elsevier (2007).
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Hen egg white lysozyme was employed as a model 
protein so as to evaluate the dynamic binding capac-
ity of a fibrous cation exchanger material produced 
according to the gPore technology (SP-gPore). The 
packed fibrous adsorbent allowed for operational flow 
rates between 40 and 350 cm/h. Under such experi-
mental conditions, capacity values were found in the 
range of 160 to 280 mg protein/g adsorbent.
To evaluate the resolution power of the packed 
fibrous adsorbent (SP-gPore), chromatography cycles 
were run utilizing an increased gradient development 
(20 CV) and employing a mixture of three com-
mercially available proteins. As shown in Figure  8, 
with three different flow rates the SP-gPore mate-
rial showed a very good resolution, which could be 
maintained even at high flow rates, that is, of up to 
900 cm/h. Therefore, flow rates can be increased by 
a factor of six while maintaining a similar chromato-
graphic behaviour in terms of resolution power. It can 
be observed that resolution at high flow rate has been 
better than commonly observed for a beaded material 
(SP Sepharose) [115]. The combination of both factors 
allows for the reduction of buffer consumption by 
gradient shrinking during the process development 
and leads to a decrease in working time, improving 
overall chromatographic productivity.
Another advantage provided by the fibrous adsor-
bent systems is the low-pressure drop observed dur-
ing chromatography, especially at high flow rates. 
The permeability coefficient calculated according to 
Darcy’s Law at a low Reynolds number yielded a value 
of 1 × 10−7 cm2 for a fibre-packed column [115]. As a 
comparison, this value is two times higher than the 
values of columns packed with ion-exchange beads 
[116,117]. Although many factors can influence perme-
ability, fibre compactness is one of the most important 
factors determining the observed column back pres-
sure. Considering that the permeability value reported 
above was measured with a very compact configura-
tion of the fibrous web, more open fibre configura-
tions will most likely lead to even better back pressure 
performance. Moreover, adsorptive fibres can be easily 
arranged in an open structure that allows biomass tol-
erance while retaining its hydrodynamic features. This 
characteristic becomes an advantage, as it results in 
simplifying the recovery of bioproducts directly from 
a cell-containing feedstock.
In regard to the structure of the packing, different 
arrangements have been studied in the form of stacked 
discs, simple rolls, or in parallel or twirled arrange-
ments, either in packed or open forms in randomly and 
non-randomly packed beds. A column with SP-gPore 
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fibres in a non-randomly packed open structure double 
roll was tested to demonstrate the ability to process a 
cell containing feed stream (Figure 9).
An artificial mixture composed of 5 g/l lysozyme 
(as a model protein for purification) and 1.5% dis-
rupted yeast cells was employed to realistically simu-
late process conditions generally encountered during 
the direct purification of macromolecules from a par-
ticle containing feedstock. The whole fragmented cell 
suspension was applied to a cartridge containing the 
fibrous adsorbent, employing a system based on peri-
staltic pumps with a linear flow velocity of 150 cm/h. 
After washing with the loading mobile phase, the elu-
tion of the target protein lysozyme was carried out by 
increasing the conductivity of the mobile phase; the 
resulting chromatogram elution profile is shown in 
Figure  9 [115]. Lysozyme is selectively bound to gPore 
and recovered as pure protein from either biomass-
filtered or biomass-unfiltered feedstock. The mate-
rial shows almost no back pressure and no clumps, 
indicating high biomass compatibility. More recently, 
these adsorptive fibres were arranged in an optimized 
non-woven fabric as a single-use device, in order to 
standardize an adsorptive matrix for an industrial 
production process. Furthermore, gPore has made sig-
nificant strides in overcoming some of the drawbacks 
of packed fibres that have prevented high through-
put and binding capacities, including low porosities, 
irregular packing, and most importantly, low biomass 
compatibility [118,119].
At present, the adsorptive separation of bioproducts 
can be attained utilizing beaded supports, perfusive 
monoliths, or membrane adsorbents, all of which have 
found industrial applications in various bioprocess-
ing niches (see Table 3 for a general comparison). The 
recent availability of packed fibrous adsorbents, which 
are amenable for highly productive and cost-effective 
bio-separations, will add a powerful tool to the current 
downstream processing portfolio.
Future perspective
The biopharmaceutical industry is growing at an 
unprecedented rate, especially with regard to complex 
therapeutic molecules, such as mAb [120]. While it will 
remain a cost-intensive endeavour to develop and bring 
such products to the market, significant cost-reduction 
potential can be realized by incorporating innovative 
methodologies in downstream bioprocessing early on 
into the development process. These methodologies 
should be able to satisfy the ever-increasing global 
800
1000
600
400
A
b
so
rb
an
ce
 (
m
A
u
)
Volume (ml)
E
lu
ti
o
n
 b
u
ff
er
 (
%
)
1200
200
1400
0
0
80
60
40
20
100Elution peak
250200150100500
Lysozyme absorgance
Concentration of elution buffer
Figure 9. Experiment for biomass tolerance of SP gPore under simulated process conditions. Lysozyme was 
mixed with yeast cells and applied to the column with SP gPore. Subsequently, the column was washed and the 
lysozyme eluted (peak at 150 ml).  
Reproduced with permission from [115] © Elsevier (2012).
Review
436 future science groupPharm. Bioprocess. (2013) 1(5)
consumer demand for high quality bioproducts, which 
will play a much more prominent role in the future. 
Process integration and intensification should be a key 
feature in the design of new bioprocesses. In this regard, 
techniques such as aqueous two-phase extraction can 
be a valuable alternative to conventional solid–liquid 
separation techniques and high-resolution techniques, 
although EBA chromatography has the potential to 
surpass traditional technologies in this field as well. 
They allow integrating the clarification, concentration 
and capture of biomolecules from crude feedstocks in a 
single unit operation, with high selectivity and recov-
ery. The challenges posed by new classes of bioproducts 
require a paradigm shift in approaches for their capture 
and purification. Together with ATPS and EBA, con-
vective flow systems have also been shown to possess 
distinctive advantages in meeting these challenges. In 
terms of enhancements to traditional chromatography 
methods, disposable, cost-effective, and high perfor-
mance adsorbent materials, which also allow for shorter 
process times and lower consumption, have matured 
in the form of fibre-based adsorbents, such as gPore. In 
the coming years, as new classes of biotherapeutics are 
developed, continuous-mode adaptions and combina-
tions of these technologies will be needed in order to 
usher them to the market.
It is noteworthy that the technologies discussed in 
this review are not mutually exclusive, and should be 
viewed as complementary and versatile tools in the 
arsenal of modern industrial bioprocess technology.
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Executive summary
Background
 » The cost intensive nature of pharmaceutical production have pushed downstream processing needs and 
requirements into the focus of research, especially for new molecule classes, that is, pDNA or virus-like particles
 » Integration and intensification are the biggest challenges faced by downstream technologies.
 » Transformation from batch-based to more economical continuous processing is an important recent 
development, attracting a lot of attention.
Aqueous two-phase separation
 » Aqueous two-phase separation technology is especially suited to early purification, due to its ability to handle 
solid containing feedstock, integrating clarification and capture.
 » Possible to be operated in a continuous mode.
Second generation expanded bed adsorption chromatography
 » Expanded bed adsorption is based upon a fluidized bed, on which crude feedstock can be directly loaded, 
thereby integrating clarification, capture, and concentration in a single step.
 » Novel bead materials have been developed, which have tackled several problems previously plaguing this 
methodology, and have allowed the full potential of expanded bed adsorption to be realized.
Convective flow systems
 » Mass transfer in methacrylate monolithic columns, which are easily scalable, is based on convection leading 
to flow-independent resolution and binding capacity for all sizes of biopharmaceuticals leading to shorter 
separation time and higher productivity.
 » The decrease in contact time of the target molecule with the chromatographic support is important for labile 
molecules as this reduces the possibility of conformational changes in their structure.
 » The structure of methacrylate monoliths with highly connected flow through pores (with the pore diameter of 
up to 6 mm) enables purification of very large molecular entities such as viruses, virus-like particles, pDNA 
and others with high process yield.
Fibre-based adsorbent systems
 » Disposable purification technologies can be based on functionalized naturally occurring fibres, for example 
cotton, which is a cheap and renewable starting material.
 » The benevolent physico-chemical characteristics and ability to be functionalized with a wide variety of 
different moieties makes for a versatile and flexible system.
Future perspective
 » The new technologies allow considerable savings to be realized, leading to cheaper medication and other 
classes of bioproducts.
 » The emergence of new classes of biopharmaceuticals has evoked a paradigm shift in the industry from 
established downstream processes.
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